Patience Afokailu Akpobome, FNP NP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: Gmw Health 31315 Fm 2920 Rd Suite 3,, Waller, TX 77484 Phone: 936-372-3003 |
Cristina Roberts, Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 975 Bowler Rd, Waller, TX 77484 Phone: 832-646-4182 |
Cajetan Sajulga Iii, APN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 19001 Kermier Road, Waller, TX 77484 Phone: 936-931-5200 Fax: 936-931-5208 |
Ms. Geraldine Wilson, APN/FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 31315 Fm 2920 Rd, Suite 6, Waller, TX 77484 Phone: 936-372-3003 Fax: 936-372-9013 |
Pamela A Odima, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 31315 Fm 2920 Rd Ste 3, Waller, TX 77484 Phone: 936-372-3003 |
Mrs. Sangsoo Cho, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 31303 Fm 2920 Rd, G, Waller, TX 77484 Phone: 936-931-3448 Fax: 936-931-3704 |
Valerie Camille Richard, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 31303 Fm 2920 Rd, Suite G, Waller, TX 77484 Phone: 936-931-3448 Fax: 936-931-3704 |
News Archive
There is a great deal of excitement around virtual reality (VR) headsets that display a computer-simulated world and augmented reality (AR) glasses that overlay computer-generated elements with the real world.
Brazos Private Equity Partners, LLC, a leading Dallas-based private investment firm, today announced that it has agreed to sell its portfolio company, Vision Source, to Essilor of America, Inc., a subsidiary of Paris-based Essilor International and the leading manufacturer and wholesale distributor of optical lenses in the United States.
A $1.3 million grant to Indiana University from the National Institutes of Health's Fogarty International Center will establish the East African Center of Excellence in Health Informatics.
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
When our skin is damaged, a whole set of biological processes springs into action to heal the wound. Now, researchers from the VIB-UGent Center for Inflammation Research have shown that one of the molecules involved in this, HMGB1, slows down wound healing.
› Verified 2 days ago